Capillary Technologies: ₹3,228 Cr IPO Funds Largely Unspent Post-Q4 FY26

TECH
Whalesbook Corporate News Logo
AuthorAarav Shah|Published at:
Capillary Technologies: ₹3,228 Cr IPO Funds Largely Unspent Post-Q4 FY26
Overview

Capillary Technologies India Ltd has reported that ₹3,228.95 crore of its ₹3,229.08 crore net IPO proceeds were still unspent as of March 31, 2026. The company spent ₹134.38 crore in the quarter, mainly on issue costs. However, slow spending on areas like inorganic growth is drawing investor attention, who are looking for progress on objectives such as cloud infrastructure and R&D.

Instant Stock Alerts on WhatsApp

Used by 10,000+ active investors

1

Add Stocks

Select the stocks you want to track in real time.

2

Get Alerts on WhatsApp

Receive instant updates directly to WhatsApp.

  • Quarterly Results
  • Concall Announcements
  • New Orders & Big Deals
  • Capex Announcements
  • Bulk Deals
  • And much more

Capillary Technologies Fund Utilization Update

Reported Fund Utilization

Capillary Technologies India Limited's IPO raised ₹3,450 crore gross, with net proceeds totaling ₹3,229.08 crore. For the quarter ending March 31, 2026, the company utilized ₹134.38 crore. This included ₹134.25 crore for issue expenses and a minimal ₹0.13 crore for general corporate purposes. As of the end of Q4 FY26, a substantial ₹3,228.95 crore remained unutilized from the IPO funds.

Investor Scrutiny on Fund Use

How a company deploys IPO funds is closely watched by investors as it directly impacts growth strategies. Investors typically monitor the use of capital against objectives like enhancing cloud infrastructure and investing in research and development (R&D). Significant unspent amounts can raise questions about execution progress or shifts in business priorities.

IPO Proceeds Allocation

Capillary Technologies India Ltd held its Initial Public Offer (IPO) from November 14-18, 2025. The net proceeds were earmarked for key growth areas, including cloud infrastructure and research and development (R&D). A portion was also allocated for funding inorganic growth and general corporate purposes.

Prudent Cash Management

A large portion of the capital remains available for Capillary Technologies to deploy toward its strategic objectives. The funds not yet spent are held in interest-bearing fixed deposits and monitoring accounts, suggesting a prudent approach to managing available cash while awaiting deployment.

Slow Spending on Growth Initiatives

A notable area of concern is the slow pace of utilization for funding inorganic growth and general corporate purposes. As of the close of fiscal year 2026, only ₹0.13 crore had been spent on these specific objectives. The company has attributed this slow deployment to its operating model, which relies on reimbursements.

Industry Peers

Identifying direct listed peers in India that offer a niche AI-powered customer engagement and loyalty SaaS platform similar to Capillary Technologies is difficult. Larger IT services firms like Infosys, Wipro, and TCS provide digital transformation services to the retail sector but do not directly compete as product-based rivals.

Future Monitoring

Investors will be closely watching future monitoring agency reports to track the utilization rate of the remaining ₹3,228.95 crore. Company announcements on specific plans or completed deployments for inorganic growth and R&D initiatives will also be key. Management's commentary on how the reimbursement-based model affects fund deployment timelines will be important to follow, alongside performance updates on cloud infrastructure and R&D progress.

Get stock alerts instantly on WhatsApp

Quarterly results, bulk deals, concall updates and major announcements delivered in real time.

Disclaimer:This content is for educational and informational purposes only and does not constitute investment, financial, or trading advice, nor a recommendation to buy or sell any securities. Readers should consult a SEBI-registered advisor before making investment decisions, as markets involve risk and past performance does not guarantee future results. The publisher and authors accept no liability for any losses. Some content may be AI-generated and may contain errors; accuracy and completeness are not guaranteed. Views expressed do not reflect the publication’s editorial stance.